Introduction
Glaucoma suspect patients are defined by the European glaucoma guides as patients with visual field and/or optic disc and/or retina nervous fibre layer normal or suspect, with at least one of these conditions suspected. 1 The ophthalmological guides to decide whether or not to initiate treatment for these patients are complex and depend on ocular, systemic, medical and psycho-social factors. 2 Therefore, these patients give rise to doubts among glaucoma experts when making said decision. Multiple studies have endeavored to asses the risk factors of progression to glaucoma in suspect patients. 3, 4 In their work published 2009, 5 the study group named Appropriateness of Treating Glaucoma Suspects aimed at identifying which glaucoma suspect patients are appropriate for treatment. The objective of this work is to analyze the match or concordance between the clinical decisions of our glaucoma unit and those of the expert panel of said study.
Material and methods
A retrospective study which by means of consecutive sampling included 77 patients referred to the Glaucoma Section of the Virgen de la Salud hospital. Of the total, 39 were classified as suspected primary open angle glaucoma (POAG) and 38 as ocular hypertensive (OHT). Explorations were performed following the masked method by any one of the five ophthalmologists of the Glaucoma Section of the Virgen de la Salud hospital. By default the right eye of each patient was included, or the left eye if it was the only eye fulfilling the criteria for inclusion in the study.
Ophthalmological and general clinical historical data was collected for all the patients included in the study. They had a spherical equivalent of 5 diopters or less and a cylinder defect of 3 dioptres or less. We excluded patients having risk factors for developing secondary open angle glaucoma (pseudoexfoliation, Krukenbergs spindle, characteristic iridian atrophy, history of uveitis or eye traumatism, signs of corticoid glaucoma or increased episcleral venous pressure), as well as those fulfilling glaucoma criteria due to primary or secondary angle closure determined with gonioscopy. We classified as OHT patients those who fulfilled the following criteria: intra-ocular pressure (IOP) over 21 mmHg on at least two occasions, with visual field and papilla exploration and retina nervous fibre layer normal. We classified as glaucoma suspects the individuals whose papilla had POAG indications, regardless of the IOP value, with normal or suspect visual field exploration.
The confocal laser scan images (Heidelberg Retina Tomography, HRT III) with a quality defined as acceptable or above (standard deviation = 30 µm) were included in the study. The images not fulfilling said criterion were rejected. The recorded papillary stereometric parameters were the disc Nuestro objetivo es analizar la concordancia entre las decisiones clínicas de nuestra unidad de glaucoma y la del panel de expertos.
Métodos: Estudio retrospectivo de 77 pacientes (39 sospechosos, 38 hipertensos oculares).
Se recogen datos de edad, antecedentes familiares, tamaño de disco óptico, cociente excavación/papila, presión intraocular, paquimetría y esperanza de vida. Se asignó una puntuación, a partir del esquema propuesto por el grupo de trabajo Appropriateness of Treating Glaucoma Suspects, según la cual se decide si es idóneo tratar o no hay consenso. Para analizar la concordancia se calculó el índice kappa. diameter/papilla (D/P) as well as the optic disc area. The loss of variance (LV) of the second visual field were also recorded (octopus white-white, TOP strategy) provided its results were reliable (reliability factor <15) and the time elapsed between the visual field determination and the papillary exploration with HRT III was under one month. The individuals who had been treated prior to the recorded diagnostic tests were not included in the study.
The decision taken with these patients was analyzed (to treat or not) on the basis of various risk factors: age, familial first degree history of glaucoma diagnostic.
A score was assigned according to the scheme proposed by the working group of the Appropriateness of Treating Glaucoma Suspects study as follows: age: <79 years, 0 points; >79 years, 1 point. First degree glaucoma history: no, 0 points; yes, 1 point. Optic disc size: small (<1.6 mm), 1 point; medium (1.6-2.5 mm), 0 points; large (>2. The overall score took as reference the scheme proposed by the working group of the Appropriateness of Treating Glaucoma Suspects study as follows: under total score of 3 points, not appropriate to initiate anti-glaucoma treatment. Between 3 and 6.5 points, no consensus on the need of treatment, and above 6.5 points, appropriate to initiate treatment. For the concordance analysis between the clinical decisions taken in our working group with regard to the recommendations of the expert committee, we only took into account the individuals who, according to the consensus, were admitted to treatment or not, excluding those on whom there was no agreement about the appropriateness of treatment (between 3 and 6.5 points total score).
For the statistical analysis the statistical software SPSS 10.1 was utilized. To determine significant differences between group, the t for Student test and the χ 2 tests were used. To determine the match between the D/P diameter data determined with biomicroscopy and HRT, the intraclass correlation coefficient was calculated. To establish the concordance between the clinical decisions related to treatment taken by both groups, the kappa index was calculated.
Results
The study comprised data of 77 patients, 39 classified as POAG suspects (50.6%) and 38 as OHT (49.4%). Tables 1, 2 and 3 illustrate the descriptive statistical data of the sample.
The recorded variables included statistically significant differences between both groups in relation to LV and the D/P diameter, measured with HRT III as well as with ophthalmoscopy (table 4) . These three variables were larger in suspect individuals (p<0.05). Also larger was the percentage of suspect individuals with familial history of glaucoma (p<0.05). Thirty-one individuals of the study exhibited a familial history of glaucoma, totaling 79.49% of all suspects against 31.58% of individuals with OHT (12 individuals). IOP was higher in the OHT group (p<0.05) vis-à-vis the suspect group (13 individuals had IOP values exceeding 21 mmHg).
The concordance analysis between the clinical approach of treating or not treating adopted by our study group and that recommended by the expert committee according to their scoring system, we found a global kappa index value of 0.082 (confidence interval [CI] . To obtain said value we excluded the individuals for whom there was no consensus for applying treatment (on the basis of their score) according to the expert committee (12 individuals). It was decided to treat 25 subjects, of which 22 did not have consensus in the expert committee, which decided not to treat. Of these 22 individuals (9 OHT and 13 suspect), 15 had family history. A group analysis shows that, in the cases of POAG suspects, there was agreement for therapeutic decision in 22 of the 35 analyzed cases, whereas in the OHT cases such agreement arose in 19 of the 30 analyzed cases. Of the 12 individuals in regard to which the expert committee had doubts about the benefit they would derive from treatment, for eight of them the approach taken in our working group was to treat (2 suspects and 6 OHT). Of said eight subjects, 5 exhibited a family history of glaucoma. Of the 40 subjects for whom our clinical approach was not to treat, 2 cases (OHT), by applying the expert committee scores a total of 7 points was obtained, which recommended treatment. However, in these subjects the approach of our group was not to treat at that time because the IOP was not excessively high and the functional and structural tests gave normal results. It was decided to maintain the patients in observation and follow-up.
Discussion
The concordance index between our approach and that of the expert committee was low. Of the 25 cases we decided to treat, only three matched their approach (table 5) . In most of these cases, the patients are OHT cases and have a familial history of glaucoma.
In the exploration of suspect and OHT patients in our daily practice we included perimetry and the fibre layer study with HRT III. Therefore, we take into account more variables than those included in this study and in some of these patients the results reveal the possibility that a disease may exist, which supports our approach to initiate treatment.
On the other hand, many of the subjects who were included in treatment exhibited familial glaucoma histories. We can consider that the knowledge of glaucoma through close relatives gives rise to the need of not only submitting to explorations for an early diagnostic of the disease but also to assign treatment preferences in order to prevent optic nerve damage. In these circumstances, we consider it essential to hold an interview with the patient to discuss the possibilities of initiating treatment or not. Probably here lies one of the main differences in our sample between the clinical decision we took and that advised by the expert committee. In our view, it is not the same to decide on the basis of a theoretical assumption than being face to face with actual patients who on some occasions communicate their concerns. So, if indicated, it is decided to establish treatment after said interview.
A similar situation was encountered in the group of patients for whom no consensus was obtained as regards treatment according to the expert committee and our decision was to treat the majority of them.
Said panel did not either include the possibility of follow-up of patients or their psycho-social factors, which could influence the attitude against a theoretical assumption. Table 4 -Statistically significant differences between groups
There are numerous and important studies on the need of treatment for suspect patients, like the Ocular Hypertension Treatment Study which objectively determined a reduction of the risk of developing glaucoma in OHT patients (IOP between 24 and 31 mmHg) when establishing treatment. 6 Even considering the various publications that analyze the risk factors associated to glaucoma, 7, 8 we still do not have precise clinical guides clearly indicating the need of treating these patients. 9 It is important to emphasize that our study is limited due to its retrospective nature and the reduced sample size. The thin line separating the suspicion of glaucoma from early glaucoma is frequently difficult to determine. Additional studies are needed to shed further light on this situation. 
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